French Pharmaceuticals & Biotech Nano Cap Stocks

GenSight Biologics

Market Cap: €19.6m

A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Poxel

Market Cap: €11.9m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases.

Aton

Market Cap: €11.1m

Operates as a bioscience company in France.